Locoregional immuno-chemotherapy transplenic and transtumoral in vivo immunostimulation

Hepato-Gastroenterology

Volumn 43, Issue 8, 1996, Pages 440-447

  Lygidakis, N J ^a,c   Stringaris, K ^b  

^a Athineon Hospital   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Adjuvant therapy; Locoregional immuno chemotherapy; Multi drug resistance

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; LIVER TUMOR; MEDICAL RESEARCH; PANCREAS TUMOR; PRIORITY JOURNAL; TARGET CELL; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; DRUG RESISTANCE, MULTIPLE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, LYMPHOKINE-ACTIVATED; LIVER NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029998916     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gazzaniga G.M, Cifferi E, Fazio S, Bagarolo C, Municino O, Cesare S, Cogolo L.A. Repeated Hepatic Resections for Recurrent Metastasis of Colorectal Cancer. Hepato-Gastroenterol. 1995; 42: 383-386.
2. Nagakawa T, Ueno K, Tawara T, et al. Evaluation of Long-term survivors after Pancreatoduodenectomy for Pancreatoduodenal Carcinoma. Hepato-Gastroenterol. 1995; 42: 117-122.
3. Lygidakis N.J, Ziras N, Kyparidou E, et al. Combined Immunopharmaceutical Therapy Of Patients With Unresectable Pancreatic Carcinoma. Hepato-Gastroenterol. 1995; 42: 1039-1052.
4. Lygidakis N.J. Pancreatic Head Carcinoma: Is Pancreatic Resection Indicated for Patients with Stage III Pancreatic Duct Cancer? Hepato-Gastroenterol. 1995; 42: 587-598.
5. Lygidakis N.J. New Frontiers in the Oncology of G.I. Tract. Hepato-Gastroenterol. 1995; 42: 432-437.
6. Lygidakis N.J, et al. Resection versus Resection Combined with Adjuvant Pre- and Post-Operative Chemotherapy - Immunotherapy for Metastatic Colorectal Liver Cancer. A New Look at an Old Problem. Hepato-Gastroenterol. 1995; 42: 155-161.
7. Oka M, Hazama S, Suzuki M, Ogura Y, Kobayashi N, Suzuki T. Histological Analysis of Hepatocellular Carcinoma Treated by Intraarterial Co9mbined Immunochemotherapy. Hepato-Gastroenterol. 1995; 42: 561-566.
8. Yamamoto M, Fujii H. Optimal Locoregional Immunochemotherapy after minor-mass reduction for advanced hepatocellular carcinoma. Hepato-Gastroenterol. 1995; 42: 567-577.
9. Okuno K, Yasutomi M. Locoregional Immunochemotherapy in Liver Carcinoma - Present and Future. Hepato-Gastroenterol. 1995; 42: 578-586.
10. Broxterman H.J, Jansen G, Linn SC, Lankelma J. The Impact of Transport-Associated Resistance in Anticancer Chemotherapy. Edited by Georgopapadakou NH. New York: Marcel Dekker; 1995:21-62.
11. Gibbs J.B. Raw C-Terminal processing enzymes: new drug targets. Cell 1991; 651: 1-4.
12. Kitada S, Takayama S, Deritel K, Tanaka S, Reed J. Reversal of chemoresistance of lymphoma tells by antisense - mediated reduction of bcl-2 gene expression. Antisense Res. Dev. 1994, 4: 71-90.
13. Louie D, Kant S, Brooks J, Reed J. Absence of (14:18) translocation and BCL- 2 oncogene overexpression in Reed-Sternberg cells of non-Hodgkin's disease. Amer. J. Pathol. 1994; 139: 1231-1237.
14. Bardeesy N, Beckwith J.B, Pelletier S. Clonal expansion and alternated apoptosis in Wilm's tumors are associated with P53 gene mutations. Cancer Res. 1995; 55: 215-219.
15. Uze G, Lutfalla G, Mongensen K.E. A and B Interferons and their receptors and their friends and relations. J. Interferon Res. 1995; 15: 3-26.
16. Gutterman J.U. Cytokine therapeutics: Lessons from Interferon-α. Proc. Nat. Acad. Sci, USA 1994, 91:1198-1205.
17. Deehan DJ, Heys SD, Simpson WG, Broom J, et al. In vivo Cytokine Production and Recombinant Interleukin-2 Immunotherapy: an Insight into the possible mechanism undergoing clinical responses. Br. J. Cancer 1994; 69: 1130-1135.
18. Lygidakis NJ, Stringaris K, Kokinis K, Lyberopoulos and Raptis S. Locoregional Chemotherpay versus Locoregional combined Immuno-Chemotherapy for Patients with advanced Metastatic Liver Disease of Colorectal Origin: A Prospective Randomized Study. Hepato-Gastroenterol. 1996; 43: 212-220.
19. Kitayama J, Tsuno N, Yasuhara H, Nagawa H et al. Lysses of endothelial cells by autologous lymphokine-activated killer cells. Cancer Immunol-Immunotherapy 1994; 38: 317-322.
20. Fyfe G, Fischer RI, Rosenberg SA et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant Interleukin-2 Therapy. J. Clin. Oncology 1995; 13: 688-696.
21. Atkins MB, Sparano J, Fischer RI et al. Randomized phase II trial of high-dose IL-2 either alone or in combination with Interferon-alfa in advanced renal cancer. J. Clin. Oncology 1993; 11: 661-070.
22. Marineda FM, White DE, Wise EP et al. Combination Therapy with INK-α and IL-2 for the treatment of metastatic cancer. J. Clin. Oncology 1995; 13: 1110-1122.
23. Nomoto S, Nakao A, Ichihara T, and Takagi H. Intraoperative Quick Immunoperoxidase Staining: A Useful Adjunct to Routine Pathological Diagnosis in Pancreatic Carcinoma. Hepato-Gastroenterol. 1995; 42: 717-723.
24. Kaneko T, Nakao A, Inoue S, Nomoto S, et al. Intraportal endovascular ultrasonography as a new diagnostic procedure in pancreatic surgery. Hepato-Gastroenterol. 1995; 42: 711-716.
25. Ishikawa O, Ohigashi H, Imaoka S, Takenaka A, et al. Surgical techniques of cytology-guided pancreatectomy for occult neoplasm of the pancreas. Hepato-Gastroenterol. 1995; 42: 724-729.
26. Ikeda S, Matsumoto S, Meshiro K, et al. Segmentai pancreatectomy for the diagnosis and treatment of small lesions in the neck or body of the pancreas. Hepato-Gastroenterol. 1995; 42: 730-733.
27. Nakao A, Harada A, Nonami T, Kaneko T, and Takagi H. Regional vascular resection using catheter bypass procedure for pancreatic cancer. Hepato-Gastroenterol. 1995; 42: 734-739.
28. Jorba R, Jaurrieta E, Bernat R, Verdaguer J, et al. DNA Ploidy and S+G2M Fraction (Proliferative Index) As Prognostic Determinants In Human Periampullary Cancer. Hepato-Gastroenterol. 1995; 42: 740-747.
29. Ido M, Higashiguchi T, Tanigawa K, Kawarada Y. Cell Biological Evaluation of Biliary Drainage prior to Hepatectomy in Obstructive Jaundice. Hepato-Gastroenterol. 1995; 42: 308-316.
30. Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M. Technique of Inserting Multiple Biliary Drains and Management. Hepato-Gastroenterol. 1995; 42: 323-331.
31. Shimada M, Kawahara N, Yanaga K, et al. A Refined Method of Trans-thoracoabdominal Hepatectomy for Cirrhotic Patients with Hepatocellular Carcinoma. Hepato-Gastroenterol. 1995; 42: 450-453.
32. Yanaga K, Yamamoto K, Nishizaki T, Sugimachi K, et al. A quick and simple technique for selective control of hepatic arterial bleeding. Hepato-Gastroenterol. 1995; 42: 454-455.
33. Matsumata T, Taketomi A, Shirabe K, Takenaka K et al. Morbidity and Mortality after Hepatic Resection in the Modern Era. Hepato-Gastroenterol. 42 (1995): 456-460.
34. Yamagata M, Maeda T, Ikeda Y, Shirabe K, et al. Surgical Results of Spontaneously Ruptured Hepatocellular Carcinoma. Hepato-Gastroenterol. 1995; 42: 461-464.
35. Ikeda Y, Kajiyama K, Yamagata M, Yanaga K, et al. Early Recurrence after Surgery of Hepatocellular Carcinoma. Hepato-Gastroenterol. 42 (1995): 469-472.
36. Miyakawa S, Horiguchi A, Ishihara S, et al. Arterial Reconstruction of the Posterior Segment after Central Bisegmentectomy and Caudate Lobectomy. Hepato-Gastroenterol. 1996; 43: 225-228.
37. Noun R, Elias D, Balladur P, Bismuth H, Belghiti J, et al. Fibrin Glue Effectiveness and Tolerance after Elective Liver Resection: A Randomized Trial. Hepato-Gastroenterol. 1996; 43: 221-224.
38. Tsuge H, Mimura H, Hamazaki K, Mori M, et al. Interruption of Hepatic Arterial Blood Flow After Resection of Pancreaticobiliary Carcinoma. Hepato-Gastroenterol. 1995; 42: 966-974.